BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 18521804)

  • 1. Comparison of blood tacrolimus concentrations in liver and kidney transplant recipients using ACMIA and MEIA immunoassays.
    Freire A; Hermida J; Tutor JC
    Ups J Med Sci; 2008; 113(1):103-10. PubMed ID: 18521804
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is the affinity column-mediated immunoassay method suitable as an alternative to the microparticle enzyme immunoassay method as a blood tacrolimus assay?
    Ju MK; Chang HK; Kim HJ; Huh KH; Ahn HJ; Kim MS; Kim SI; Kim YS
    Transplant Proc; 2008 Dec; 40(10):3673-8. PubMed ID: 19100463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the hematocrit and its correction on the relationship between blood tacrolimus concentrations obtained using the microparticle enzyme immunoassay (MEIA) and enzyme multiplied immunoassay technique (EMIT).
    Bouzas L; Ortega FJ; Casado P; Arranz MI; Carcas A; Tutor JC
    Clin Lab; 2007; 53(9-12):591-6. PubMed ID: 18257466
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Performance evaluation of affinity column mediated immunometric assay for tacrolimus].
    Chung JW; An D; Song J; Chung HJ; Park HI; Lee W; Chun S; Min WK
    Korean J Lab Med; 2009 Oct; 29(5):415-22. PubMed ID: 19893350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the Architect tacrolimus assay in kidney, liver, and heart transplant recipients.
    Bazin C; Guinedor A; Barau C; Gozalo C; Grimbert P; Duvoux C; Furlan V; Massias L; Hulin A
    J Pharm Biomed Anal; 2010 Dec; 53(4):997-1002. PubMed ID: 20674215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low plasma concentrations of albumin influence the affinity column-mediated immunoassay method for the measurement of tacrolimus in blood during the early period after liver transplantation.
    Tempestilli M; Di Stasio E; Basile MR; Elisei F; Antonini M; Ettorre GM; Iappelli M; Pucillo LP
    Ther Drug Monit; 2013 Feb; 35(1):96-100. PubMed ID: 23191996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is microparticle enzyme-linked immunoassay (MEIA) reliable for use in tacrolimus TDM? Comparison of MEIA to liquid chromatography with mass spectrometric detection using longitudinal trough samples from transplant recipients.
    Napoli KL
    Ther Drug Monit; 2006 Aug; 28(4):491-504. PubMed ID: 16885716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards.
    Rostaing L; Cointault O; Marquet P; Josse AG; Lavit M; Saint-Marcoux F; Kamar N
    Transpl Int; 2010 Feb; 23(2):227-30. PubMed ID: 19761555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic monitoring of tacrolimus concentrations in blood of renal and liver transplant recipients: comparison of microparticle enzyme immunoassay and enzyme multiplied immunoassay methods.
    Bartlomiejczyk I; Zochowska D; Sanko-Resmer J; Matuszewicz D; Paczek L
    Transplant Proc; 2006; 38(1):94-6. PubMed ID: 16504673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of sample hematocrit value to correct blood tacrolimus concentration derived by microparticle enzyme immunoassay.
    Tomita T; Homma M; Hasegawa Y; Kojima H; Ohkohchi N; Hori T; Kaneko M; Nakano Y; Tobe T; Kohda Y
    Biol Pharm Bull; 2008 Jun; 31(6):1250-3. PubMed ID: 18520063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients.
    Hashi S; Masuda S; Kikuchi M; Uesugi M; Yano I; Omura T; Yonezawa A; Fujimoto Y; Ogawa K; Kaido T; Uemoto S; Matsubara K
    Transplant Proc; 2014 Apr; 46(3):758-60. PubMed ID: 24767342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
    Salm P; Taylor PJ; Clark A; Balderson GA; Grygotis A; Norris RL; Lynch SV; Shaw LM; Pond SM
    Ther Drug Monit; 1997 Dec; 19(6):694-700. PubMed ID: 9421113
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Falsely abnormally elevated blood trough concentration of tacrolimus measured by antibody-conjugated magnetic immunoassay in a renal transplant recipient: a case report.
    Toraishi T; Takeuchi H; Nakamura Y; Konno O; Yokoyama T; Iwamoto H; Hama K; Hirano T; Unezaki S; Okuyama K; Shimazu M
    Transplant Proc; 2012 Jan; 44(1):134-6. PubMed ID: 22310597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. More on the reliability of the microparticle enzyme immunoassay (MEIA) for therapeutic tacrolimus monitoring.
    Hermida J; Tutor JC
    Clin Lab; 2003; 49(9-10):471-4. PubMed ID: 14572203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of some hematological parameters on whole blood tacrolimus concentration measured by two immunoassay-based analytical methods.
    Akbas SH; Ozdem S; Caglar S; Tuncer M; Gurkan A; Yucetin L; Senol Y; Demirbas A; Gultekin M; Ersoy FF; Akaydin M
    Clin Biochem; 2005 Jun; 38(6):552-7. PubMed ID: 15885236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of hematocrit interference in the tacrolimus II microparticle enzyme immunoassay: a tentative approach.
    Hermida J; Fernández MC; Tutor JC
    Clin Lab; 2005; 51(1-2):43-5. PubMed ID: 15719703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of blood sirolimus concentrations in liver and kidney transplant recipients using the Innofluor fluorescence polarization immunoassay: comparison with the microparticle enzyme immunoassay and high-performance liquid chromatography-ultraviolet method.
    Bouzas L; Hermida J; Tutor JC
    Ups J Med Sci; 2009; 114(1):55-61. PubMed ID: 19242874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hematocrit influences immunoassay performance for the measurement of tacrolimus in whole blood.
    Armendáriz Y; García S; Lopez RM; Pou L
    Ther Drug Monit; 2005 Dec; 27(6):766-9. PubMed ID: 16306852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.